The healthcare expenditure on over-the-counter (OTC) medicines in Poland has shown a positive trend over the last decade, increasing from 2.79 billion Euros in 2013 to 3.88 billion Euros in 2023. Key variations include a notable drop of -0.69% in 2014, followed by a recovery with consistent growth rates, such as a 6.09% increase in 2017 and 6.99% in 2019. However, growth rates have slightly slowed in recent years, with a 2.6% increase in 2022 and 2.67% in 2023, reflecting a CAGR of 3.46% from 2018-2023. Forecasts predict a steadier expansion, with an estimated CAGR of 1.92% over the next five years, reaching 4.38 billion Euros by 2028.
Future trends to watch for include the impact of demographic changes such as an aging population, regulatory shifts influencing market accessibility, and technological advancements in healthcare which could drive higher demand and spending. Additionally, consumer behavior shifts due to increasing health awareness and preferences for self-medication could further spur OTC market growth in Poland.
